Dr Reddy's Laboratories Ltd

DRREDDY
Health CarePharmaceuticals
LargecapWith a market cap of ₹70,944 cr, stock is ranked 67
Low RiskStock is 1.54x as volatile as Nifty
4,347.1072.15 (+1.69%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹70,944 cr, stock is ranked 67
Low RiskStock is 1.54x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
32.51
PB RatioPB Ratio
4.02
Dividend YieldDiv. Yield
0.70%
Sector PESector PE
32.23
Sector PBSector PB
4.77
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

87%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Brands

Dr.Reddy's

Pharmaceutical company

Brands

Dr.Reddy's

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201920202021202215.8318.1919.3922.101.952.031.952.18
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.65%

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnMay 20, 2022

Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements | Download

Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements | Download

Disclosure of other UPSI/material event 
Announced OnMay 20, 2022

Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of presentation and the audio recording of the earnings call on Company's website. | Download

Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of presentation and the audio recording of the earnings call on Company's website. | Download

Cash Dividend 
Ex. DateJul 9, 2021

Final • Div/Share: ₹ 25

See all events